Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers
Gregory P Adams, Mei-Sheng Tai, John E McCartney, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 25, 2013
Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells
Daniel A Vallera, Bin Zhang, Michelle K Gleason, et al.
Pancreas
|
July 31, 2008
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
Steven J Cohen, R Katherine Alpaugh, Irma Palazzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 12, 2013
The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells
Sang-Soo Kim, Antonina Rait, Farwah Rubab, et al.
Molecular Cancer Therapeutics
|
March 16, 2005
Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth
Jonathan D Cheng, Matthildi Valianou, Adrian A Canutescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group
Howard L Kaufman, Wei Wang, Judith Manola, et al.
BMC Bioinformatics
|
May 1, 2016
G-DOC Plus - an integrative bioinformatics platform for precision medicine
Krithika Bhuvaneshwar, Anas Belouali, Varun Singh, et al.
Annals of Surgical Oncology
|
January 19, 2006
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report
Leonard R Henry, Melvyn Goldberg, Walter Scott, et al.
The Oncologist
|
February 20, 2026
ECOG 6293: Phase II Study of Raltitrexed in Advanced Colorectal Cancer
Chengwei Peng, Paul Catalano, John Zalcberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2008
Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies
Louis M Weiner, Arie S Belldegrun, Jeffrey Crawford, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers
Gregory P Adams, Mei-Sheng Tai, John E McCartney, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 25, 2013
Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells
Daniel A Vallera, Bin Zhang, Michelle K Gleason, et al.
Pancreas
|
July 31, 2008
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
Steven J Cohen, R Katherine Alpaugh, Irma Palazzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 12, 2013
The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells
Sang-Soo Kim, Antonina Rait, Farwah Rubab, et al.
Molecular Cancer Therapeutics
|
March 16, 2005
Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth
Jonathan D Cheng, Matthildi Valianou, Adrian A Canutescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group
Howard L Kaufman, Wei Wang, Judith Manola, et al.
BMC Bioinformatics
|
May 1, 2016
G-DOC Plus - an integrative bioinformatics platform for precision medicine
Krithika Bhuvaneshwar, Anas Belouali, Varun Singh, et al.
Annals of Surgical Oncology
|
January 19, 2006
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report
Leonard R Henry, Melvyn Goldberg, Walter Scott, et al.
The Oncologist
|
February 20, 2026
ECOG 6293: Phase II Study of Raltitrexed in Advanced Colorectal Cancer
Chengwei Peng, Paul Catalano, John Zalcberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2008
Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies
Louis M Weiner, Arie S Belldegrun, Jeffrey Crawford, et al.
Page
of 14